Relay Therapeutics, Inc. (RLAY) DCF Valuation

Relay Therapeutics, Inc. (RLAY) DCF Valuation
  • ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
  • ✓ Design Profissional: Modelos Confiáveis ​​E Padrão Da Indústria
  • ✓ Pré-Construídos Para Uso Rápido E Eficiente
  • ✓ Não É Necessária Experiência; Fácil De Seguir

Relay Therapeutics, Inc. (RLAY) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Gain insight into your Relay Therapeutics, Inc. (RLAY) valuation analysis using our sophisticated DCF Calculator! Loaded with real data for (RLAY), this Excel template enables you to adjust forecasts and assumptions to accurately determine the intrinsic value of Relay Therapeutics, Inc.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 82.7 3.0 1.4 25.5 22.3 19.5 17.0 14.8 13.0
Revenue Growth, % 0 0 -96.34 -54.41 1749.82 -12.69 -12.69 -12.69 -12.69 -12.69
EBITDA -81.2 -52.2 -222.2 -306.8 -374.2 -11.7 -10.3 -9.0 -7.8 -6.8
EBITDA, % 100 -63.21 -7335.16 -22217.38 -1464.62 -52.64 -52.64 -52.64 -52.64 -52.64
Depreciation 2.8 3.5 3.9 4.1 5.3 14.5 12.7 11.1 9.6 8.4
Depreciation, % 100 4.29 129.58 299.06 20.63 64.98 64.98 64.98 64.98 64.98
EBIT -84.0 -55.8 -226.1 -311.0 -379.4 -11.9 -10.4 -9.1 -7.9 -6.9
EBIT, % 100 -67.51 -7464.74 -22516.44 -1485.25 -53.5 -53.5 -53.5 -53.5 -53.5
Total Cash 355.8 678.1 958.1 998.9 750.1 22.3 19.5 17.0 14.8 13.0
Total Cash, percent .0 .0 .0 .1 .0 .0 .0 .0 .0 .0
Account Receivables .0 82.7 4.9 5.2 .0
Account Receivables, % 100 100 163.09 377.91 0
Inventories .0 -238.1 -682.5 12.1 .0 .0 .0 .0 .0 .0
Inventories, % 100 -288.03 -22531.89 876.9 0 0 0 0 0 0
Accounts Payable 7.0 6.4 8.3 10.6 9.2 15.3 13.4 11.7 10.2 8.9
Accounts Payable, % 100 7.68 273.23 765.97 36.06 68.75 68.75 68.75 68.75 68.75
Capital Expenditure -8.0 -1.9 -3.5 -9.1 -4.1 -9.7 -8.5 -7.4 -6.5 -5.7
Capital Expenditure, % 100 -2.34 -114.59 -656.19 -16.15 -43.7 -43.7 -43.7 -43.7 -43.7
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -74.2 -52.2 -308.7 -272.2 -379.4 -11.2 -9.8 -8.5 -7.5 -6.5
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -72.4 104.2 215.8 -969.7 -362.3 -18.2 -5.3 -4.6 -4.1 -3.5
WACC, % 11.59 11.61 11.64 11.59 11.64 11.61 11.61 11.61 11.61 11.61
PV UFCF
SUM PV UFCF -28.5
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -4
Terminal Value -38
Present Terminal Value -22
Enterprise Value -50
Net Debt -90
Equity Value 40
Diluted Shares Outstanding, MM 123
Equity Value Per Share 0.33

What You Will Get

  • Real RLAY Financial Data: Pre-filled with Relay Therapeutics’ historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See Relay Therapeutics’ intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • Real-Life RLAY Data: Pre-filled with Relay Therapeutics’ historical financials and future projections.
  • Fully Customizable Inputs: Modify revenue growth, margins, WACC, tax rates, and capital expenditures to fit your analysis.
  • Dynamic Valuation Model: Automatic recalculations of Net Present Value (NPV) and intrinsic value based on your parameters.
  • Scenario Testing: Develop multiple forecasting scenarios to evaluate various valuation results.
  • User-Friendly Design: Intuitive, organized, and crafted for both professionals and newcomers.

How It Works

  • Step 1: Download the prebuilt Excel template featuring Relay Therapeutics, Inc.'s (RLAY) data.
  • Step 2: Navigate through the pre-filled sheets to familiarize yourself with the essential metrics.
  • Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
  • Step 4: Instantly see the recalculated results, including Relay Therapeutics, Inc.'s (RLAY) intrinsic value.
  • Step 5: Utilize the outputs to make informed investment decisions or create detailed reports.

Why Choose This Calculator?

  • User-Friendly Interface: Perfectly crafted for both novices and seasoned professionals.
  • Customizable Inputs: Adjust parameters effortlessly to suit your financial analysis.
  • Real-Time Feedback: Watch as Relay Therapeutics’ (RLAY) valuation updates instantly with your changes.
  • Preloaded Data: Comes equipped with Relay Therapeutics’ actual financial metrics for swift evaluations.
  • Endorsed by Experts: A go-to tool for investors and analysts aiming for well-informed choices.

Who Should Use This Product?

  • Healthcare Professionals: Understand drug development processes and apply them to real-world scenarios.
  • Researchers: Integrate advanced modeling techniques into studies or clinical trials.
  • Investors: Evaluate your investment strategies and analyze the performance metrics for Relay Therapeutics, Inc. (RLAY).
  • Pharmaceutical Analysts: Enhance your analysis with a tailored, comprehensive DCF model specific to biotech.
  • Entrepreneurs: Discover how biotech companies like Relay Therapeutics, Inc. (RLAY) are assessed in the market.

What the Template Contains

  • Preloaded RLAY Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.

No products were found matching.